Abstract titles & Authors

OR19-01 – Sensitive measurement of clinically relevant factor VIII levels in thrombin generation assays requires presence of factor XIa – Tom van de Berg, The Netherlands

OR19-02 – Implementing andexanet alfa in the hospital – practical experience and learning points- Melanie Acampo-de Jong, The Netherlands

OR19-03 – Patients with hemophilia A have increased levels of circulating activated protein C: potential contribution to their hemostatic status- Isabel Aleman-Cabrera, Spain

OR19-04 – Identification of FXI monomers in plasma: function, clearance and relevance of Cys339- Juan José Rojo-Carrillo, Spain